U.S. Marine and Shipping Stock News

NasdaqGS:INTA
NasdaqGS:INTASoftware

Intapp Expands AI Timekeeping As Shares Trade Below Analyst Targets

Intapp (NasdaqGS:INTA) has introduced new AI powered features in Intapp Time, focused on helping professional services firms manage time and revenue capture more efficiently. The latest release includes AI work code prediction, configurable narrative tone enforcement, and upgraded mobile timekeeping tools. The update expands the use of AI across Intapp's cloud product suite for professional services clients. Intapp operates in the professional services technology space, where firms depend...
NYSE:CTRA
NYSE:CTRAOil and Gas

A Look At Coterra Energy (CTRA) Valuation After Its Form 15 Deregistration Move

Coterra Energy (CTRA) has moved to voluntarily deregister its common stock and several senior notes by filing Form 15 with the SEC, marking a material shift in its reporting and disclosure obligations for investors. See our latest analysis for Coterra Energy. The share price has reacted sharply around these filings, with a 1-day share price return down 8.62% and a 7-day share price return down 7.97%. This follows a year-to-date share price return of 22.41% and a 1-year total shareholder...
NasdaqCM:NGEN
NasdaqCM:NGENPharmaceuticals

Assessing NervGen Pharma (NasdaqCM:NGEN) Valuation After Its $60 Million Follow On Equity Offering

NervGen Pharma (NGEN) has drawn fresh attention after completing a follow on public equity offering of approximately $60 million, including common shares and warrants, to fund its neuroreparative drug development programs. See our latest analysis for NervGen Pharma. The follow on offering has coincided with sharp share price pressure, with NervGen Pharma’s 1 day share price return down 43.48% and its year to date share price return down 64.63%. This comes even though the 5 year total...
NYSE:LUXE
NYSE:LUXESpecialty Retail

Assessing LuxExperience B.V (LUXE) Valuation After Wider Losses And YNAP And THE OUTNET Reshaping

LuxExperience B.V (LUXE) drew fresh attention after reporting third quarter and nine month results that paired higher sales with a wider net loss, while also closing the sale of THE OUTNET and outlining a YNAP transformation plan. See our latest analysis for LuxExperience B.V. The latest quarter, with higher sales but a wider loss and fresh restructuring charges, has coincided with pressure on the stock, which is down 21.31% on a 1 month share price basis and 22.53% on a 1 year total...
NasdaqGS:GENB
NasdaqGS:GENBBiotechs

Can Nvidia’s Backing Reframe Generate Biomedicines (GENB) as a Scaled AI Drug Developer?

Earlier in May 2026, Nvidia invested US$10.40 million in Generate Biomedicines, an AI-driven biotech now advancing several drug candidates through clinical development, including a Phase 3 severe asthma program and oncology therapies with FDA Fast Track status. This combination of external validation from a major AI leader and visible clinical momentum underscores how AI-enabled drug discovery is moving from concept toward real-world testing. Next, we’ll examine how Nvidia’s investment and...